All Stories

  1. Effects of Clay Therapy on Emotional and Physical Outcomes in Hospitalized Pediatric Cancer Patients: A Prospective Pilot Study
  2. Genotoxic Chemotherapy in Li-Fraumeni Syndrome: Molecular Mechanisms, Clinical Consequences, and Alternative Therapeutic Strategies
  3. Medulloblastoma in Adolescents and Young Adults: Molecular Subgroups, Prognostic Biomarkers, and Age-Specific Therapeutic Challenges
  4. Diencephalic Syndrome: Clinical Features, Pathophysiology, and Long-Term Outcomes
  5. EZHIP in Pediatric Brain Tumors: From Epigenetic Mimicry to Therapeutic Vulnerabilities
  6. Adolescent Renal Tumours: Diagnostic and Therapeutic Challenges in a Transitional Age Group—A Multidisciplinary Case Report Series from a Single Center
  7. Recommended phase 2 dose for abemaciclib in combination with irinotecan and temozolomide in pediatric and young adult patients with relapsed/refractory solid tumors: Results from JPCS study (Part A)
  8. Solid Tumors in RASopathies: Insights from a Large Monocentric Cohort and Systematic Review of the Literature
  9. Trabectedin–irinotecan as a potential therapeutic option in desmoplastic small round cell tumor: A small case series
  10. The influence of tumor location on the onset of endocrine deficits in pediatric brain tumor survivors
  11. Metronomic Chemotherapy: An Alternative Strategy in Cancer Treatment Based on Continuous Low-Dose Administration
  12. Sport Activities for Children and Adolescents: Part 2. Joint Position Statement of Paediatric Societies on Physical Activity and Sport Recommendations for Children With Specific Chronic Disease Conditions
  13. Museum-based therapeutic interventions in pediatric oncology: the ETRU4KIDS experience as a model for hospital wellness enhancement
  14. Platinum-Induced Ototoxicity in Pediatric Cancer Patients: A Comprehensive Approach to Monitoring Strategies, Management Interventions, and Future Directions
  15. Spatial Analysis Identifies CD147 as a Novel Marker of High-Grade Childhood Posterior Fossa Ependymoma
  16. Medulloblastoma in Adolescents and Young Adults (AYA): Bridging Pediatric Paradigms and Adult Oncology Practice
  17. Acquisition matters - how do scan parameters affect apparent diffusion coefficient estimates in pediatric rhabdomyosarcoma
  18. Platinum-induced ototoxicity and hearing impairment in children and adolescents
  19. Editorial: Adverse and toxic effects of childhood cancer treatments, volume II
  20. Elevating fungal care: bridging Brazil’s healthcare practices to global standards
  21. Burnout in Pediatric Oncology: Team Building and Clay Therapy as a Strategy to Improve Emotional Climate and Group Dynamics in a Nursing Staff
  22. Burnout in Pediatric Oncology: Team Building and Clay Therapy as a Strategy to Improve Emotional Climate and Group Dynamics
  23. Surgical Treatment of Solid Pseudopapillary Tumor in Pediatric Patients: Two Case Reports and a Brief Narrative Review
  24. Outcomes and Toxicity of Adult Medulloblastoma Treated with Pediatric Multimodal Protocols: A Single-Institution Experience
  25. Nutritional Challenges in Paediatric Oncology: Screening and Managing Malnutrition and Sarcopenia
  26. Malnutrition and sarcopenia in children with cancer
  27. Bioelectrical Impedance Analysis of Body Composition in Male Childhood Brain Tumor Survivors
  28. Characteristics and Management of Children with Appendiceal Neuroendocrine Neoplasms: A Single-Center Study
  29. Pathogenic G6PD variants: Different clinical pictures arise from different missense mutations in the same codon
  30. Central nervous system pediatric multi-disciplinary tumor board: a single center experience
  31. Longitudinal changes in retinal ganglion cell function in optic pathway glioma evaluated by photopic negative response
  32. The Role of the Cerebellum in Advanced Cognitive Processes in Children
  33. Characterization of the malignant cells and microenvironment of infantile fibrosarcoma via single-cell RNA sequencing
  34. Childhood Obesity and Metabolic Syndrome: A Review
  35. Prevalence of burnout and psycho-emotional disorders among non-health workers: a single tertiary care pediatric oncology center experience
  36. Psychological Experiences of Parents of Pediatric Cancer Patients during and after COVID-19 Pandemic
  37. Anthropometric parameters as a tool for the prediction of metabolic and cardiovascular risk in childhood brain tumor survivors
  38. Evaluation of Metabolic and Cardiovascular Risk Measured by Laboratory Biomarkers and Cardiopulmonary Exercise Test in Children and Adolescents Recovered from Brain Tumors: The CARMEP Study
  39. Neonatal outcomes and follow-up of children born to women with pregnancy-associated cancer: a prospective observational study
  40. Predicting the next pandemic: VACCELERATE ranking of the World Health Organization's Blueprint for Action to Prevent Epidemics
  41. Intranasal human-recombinant NGF administration improves outcome in children with post-traumatic unresponsive wakefulness syndrome
  42. Timing and chemotherapy association for 131-I-MIBG treatment in high-risk neuroblastoma
  43. Tyrosine Kinase Inhibitors and Thyroid Toxicity
  44. Aminoglycosides-Related Ototoxicity: Mechanisms, Risk Factors, and Prevention in Pediatric Patients
  45. Quantitative diffusion-weighted MRI response assessment in rhabdomyosarcoma: an international retrospective study on behalf of the European paediatric Soft tissue sarcoma Study Group Imaging Committee
  46. Retrospective Study on Staphylococcus aureus Resistance Profile and Antibiotic Use in a Pediatric Population
  47. Long term use of eltrombopag in children with chronic immune thrombocytopenia: extended real life retrospective multicenter experience of the Italian Association of Pediatric Hematology and Oncology
  48. The Italian version of the Pediatric Quality of Life Inventory™ (PEDSQL™) 3.0 healthcare satisfaction hematology/oncology module: reliability and validity in radiation oncology
  49. Pregnancy-associated Cancer and Chemotherapy during Pregnancy
  50. GAU-PED study for early diagnosis of Gaucher disease in children with splenomegaly and cytopenia
  51. Drug Repurposing in Pediatric Brain Tumors: Posterior Fossa Ependymoma and Diffuse Midline Glioma under the Looking Glass
  52. Left Ventricular-Arterial Coupling and Vascular Function in Childhood Cancer Survivors Exposed to Anthracycline Chemotherapy
  53. Bisphosphonates: From Pharmacology to Treatment
  54. Successful stem cell collection for atypical teratoid rhabdoid tumor in an extremely low‐body weight child: A case report
  55. Atypical Teratoid Rhabdoid Tumor: Proposal of a Diagnostic Pathway Based on Clinical Features and Neuroimaging Findings
  56. Early and Long-Term Ototoxicity Noted in Children Due to Platinum Compounds: Prevalence and Risk Factors
  57. Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers
  58. Optic Pathway Gliomas: The Trends of Basic Research to Reduce the Impact of the Disease on Visual Function
  59. Telomerase and Anticancer Treatment
  60. Pediatric low-grade glioma and neurofibromatosis type 1: A single-institution experience
  61. The Italian Version of the Pediatric Quality of Life Inventory™ (Pedsql™) 3.0 Healthcare Satisfaction Hematology/oncology Module: Reliability and Validity in Radiation Oncology
  62. Induction Regimen in High-Risk Neuroblastoma: A Pilot Study of Highly Effective Continuous Exposure of Tumor Cells to Radio-Chemotherapy Sequence for 1 Month. The Critical Role of Iodine-131-Metaiodobenzylguanidine
  63. Serum Biomarkers for the Detection of Cardiac Dysfunction in Childhood Cancers Receiving Anthracycline-Based Treatment
  64. Catheter-related complications in onco-hematologic children: A retrospective clinical study on 227 central venous access devices
  65. BRAF and MEK Targeted Therapies in Pediatric Central Nervous System Tumors
  66. The DNA-topoisomerase Inhibitors in Cancer Therapy
  67. Transplacental Passage and Fetal Effects of Antineoplastic Treatment during Pregnancy
  68. Growth hormone replacement therapy in pediatric brain tumor survivors
  69. Biomarkers Predictive of Metabolic Syndrome and Cardiovascular Disease in Childhood Cancer Survivors
  70. Clostridioides difficile Infection in Children: A 5-Year Multicenter Retrospective Study
  71. Oral Microbiota during Childhood and Its Role in Chemotherapy-Induced Oral Mucositis in Children with Cancer
  72. Diencephalic Syndrome Due to Optic Pathway Gliomas in Pediatric Patients: An Italian Multicenter Study
  73. Nutritional status in the pediatric oncology patients
  74. Hematological disorders in children with Down syndrome
  75. Clinical Impact of Nutritional Status and Sarcopenia in Pediatric Patients with Bone and Soft Tissue Sarcomas: A Pilot Retrospective Study (SarcoPed)
  76. Long-term auditory follow-up in the management of pediatric platinum-induced ototoxicity
  77. Cell-of-Origin and Genetic, Epigenetic, and Microenvironmental Factors Contribute to the Intra-Tumoral Heterogeneity of Pediatric Intracranial Ependymoma
  78. Mechanisms, Characteristics, and Treatment of Neuropathic Pain and Peripheral Neuropathy Associated with Dinutuximab in Neuroblastoma Patients
  79. Role of Partial Splenectomy in Hematologic Childhood Disorders
  80. Editorial: Adverse and Toxic Effects of Childhood Cancer Treatments
  81. Prognostic impact of sarcopenia in children with cancer: a focus on the psoas muscle area (PMA) imaging in the clinical practice
  82. Treatment and outcome of intracranial ependymoma after first relapse in the 2nd AIEOP protocol
  83. Acute Tumor Lysis Syndrome: A Metabolic Emergency in Cancer Patients
  84. The Role of Bisphosphonates in Childhood Diseases
  85. Psychological Impact of COVID-19 on Parents of Pediatric Cancer Patients
  86. Transdermal buprenorphine for pain management in children
  87. 131-I-metaiodobenzylguanidine and chemotherapy for advanced neuroblastoma
  88. ALK ‐rearranged histiocytosis: Report of two cases with involvement of the central nervous system
  89. Diffuse Intrinsic Pontine Glioma (DIPG): Breakthrough and Clinical Perspective
  90. Cardiac Surveillance for Early Detection of Late Subclinical Cardiac Dysfunction in Childhood Cancer Survivors After Anthracycline Therapy
  91. Vincristine-Induced Peripheral Neuropathy (VIPN) in Pediatric Tumors: Mechanisms, Risk Factors, Strategies of Prevention and Treatment
  92. hTERT Transduction Extends the Lifespan of Primary Pediatric Low-Grade Glioma Cells While Preserving the Biological Response to NGF
  93. Pediatric ERCP with a single-use duodenoscope in an immunocompromised child
  94. Management of Oral Mucositis in Children With Malignant Solid Tumors
  95. The Multidimensional Assessment for Pediatric Patients in Radiotherapy (M.A.P.-RT) Tool for Customized Treatment Preparation: RADAR Project
  96. The BET Inhibitor OTX015 Exhibits In Vitro and In Vivo Antitumor Activity in Pediatric Ependymoma Stem Cell Models
  97. Contactless: a new personalised telehealth model in chronic pediatric diseases and disability during the COVID-19 era
  98. Editorial for the series on pain therapy
  99. Intranasal drugs for analgesia and sedation in children admitted to pediatric emergency department: a narrative review
  100. Narrative review of intrathecal drug delivery (IDD): indications, devices and potential complications
  101. Opioid transdermal delivery system: a useful method for pain management in children
  102. Managing children with brain tumors during the COVID-19 era: Don’t stop the care!
  103. Management of Children with Optic Gliomas and Neurofibromatosis Type 1
  104. Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium
  105. Psychological impact of COVID-19 on parents of pediatric cancer patients
  106. Targeting the mitogen‑activated protein kinase kinase and protein kinase A pathways overcomes acquired resistance to Selumetinib in low‑grade glioma cells
  107. Second series by the Italian Association of Pediatric Hematology and Oncology of children and adolescents with intracranial ependymoma: an integrated molecular and clinical characterization with a long-term follow-up
  108. Treatment and Long-Term Sequelae in Childhood Brain Tumors
  109. Cisplatin-induced nephrotoxicity in children: what is the best protective strategy?
  110. Childhood Medulloblastoma: Old Challenges, New Perspectives
  111. Bone and Soft Tissue Sarcoma
  112. Phase II results from a phase I/II study to assess the safety and efficacy of weekly nab-paclitaxel in paediatric patients with recurrent or refractory solid tumours: A collaboration with the European Innovative Therapies for Children with Cancer Network
  113. CN133, a Novel Brain-Penetrating Histone Deacetylase Inhibitor, Hampers Tumor Growth in Patient-Derived Pediatric Posterior Fossa Ependymoma Models
  114. Diagnosis of COVID‐19 infection in children: Less nasopharyngeal swabs, more saliva
  115. Temozolomide and oral etoposide in children with recurrent malignant brain tumors
  116. Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure
  117. Assessment and Management of Platinum-Related Ototoxicity in Children Treated for Cancer
  118. Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure
  119. Facing the COVID-19 outbreak in children with cancer
  120. Additional hypotheses about why COVID‐19 is milder in children than adults
  121. Covid-19 and children with cancer: are they at increased risk of infection?
  122. Multifocal infantile haemangiomatosis with hepatic involvement: two cases and treatment management
  123. Efficacy of Temozolomide in Children with Solid Tumors
  124. Gynecological cancer among adolescents and young adults (AYA)
  125. Use of Eltrombopag in Children With Chronic Immune Thrombocytopenia (ITP): A Real Life Retrospective Multicenter Experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP)
  126. Cisplatin Toxicity in Children with Malignancy
  127. Neonatal pharmacology and clinical implications
  128. Adult medulloblastoma: an overview on current and future strategies of treatment
  129. Prognostic role of pleural effusion or ascites in localized rhabdomyosarcoma
  130. Improving the Brain Delivery of Chemotherapeutic Drugs in Childhood Brain Tumors
  131. Intranasal therapy with opioids for children and adolescents with cancer: results from clinical studies
  132. Relapsed papillary urothelial neoplasm of low malignant potential (PUNLMP) of the young age: a case report and a review of the literature
  133. The impact of lacto-ovo-/lacto-vegetarian and vegan diets during pregnancy on the birth anthropometric parameters of the newborn
  134. Undifferentiated Embryonal Sarcoma of the Liver (UESL) in Adolescents
  135. Sleep and arousal disturbances in enuretic children: are there any effects on the height?
  136. Ectopic nerve growth factor prevents proliferation in glioma cells by senescence induction
  137. Social programs on providing care for children who underwent parental death and parental separation
  138. Correction to: Multimodal treatment of pediatric patients with Askin’s tumors: our experience
  139. Topotecan/carboplatin regimen for refractory/recurrent rhabdomyosarcoma in children: Report from the AIEOP Soft Tissue Sarcoma Committee
  140. Pediatric intracranial ependymoma: correlating signs and symptoms at recurrence with outcome in the second prospective AIEOP protocol follow-up
  141. Multimodal treatment of pediatric patients with Askin’s tumors: our experience
  142. The impact of motivational therapy in the management of enuretic children
  143. Focus on children murdered by parents in Italy: A sad reality
  144. Diagnostic Accuracy of 18F-FDG PET/CT in the Staging and Assessment of Response to Chemotherapy in Children With Ewing Sarcoma
  145. Acute chemotherapy-induced nausea and vomiting in children with cancer: Still waiting for a common consensus on treatment
  146. Central nervous system involvement in children and adolescents with rhabdomyosarcoma. A report from the AIEOP Soft Tissue Sarcoma Committee
  147. Oral Desmopressin Lyophilisate Formulation (MELT): Efficacy and Safety in Children and Adults
  148. Il bambino violato: aspetti moderni del maltrattamento che il pediatra deve conoscere
  149. Can partial splenectomy preserve humoral immunity in pediatric patients? Risks and benefits of partial splenectomy
  150. Safety of the Recent Oral Lyophilisate Formulation (MELT) in Pediatric Patients-A Review
  151. Renal toxicity in children receiving chemotherapy
  152. Intranasal Nerve Growth Factor administration improves cerebral functions in a child with severe traumatic brain injury: A case report
  153. Salvage rates and prognostic factors after relapse in children and adolescents with malignant peripheral nerve sheath tumors
  154. Hypersensitivity to Carboplatin in Children with Malignancy
  155. Rechallenge to Carboplatin in Children with Low Grade Glioma and Carboplatin Hypersensitivity Reactions
  156. BRAF and MEK inhibitors in pediatric glioma: new therapeutic strategies, new toxicities
  157. Erratum to: NGF eye-drops topical administration in patients with retinitis pigmentosa, a pilot study
  158. Hemophagocytic lymphohistiocytosis and visceral leishmaniasis in children: case report and systematic review of literature
  159. Management of Hyperleukocytosis
  160. Nerve growth factor improves visual loss in childhood optic gliomas: a randomized, double-blind, phase II clinical trial
  161. NGF eye-drops topical administration in patients with retinitis pigmentosa, a pilot study
  162. Audiological Monitoring in Children Treated with Platinum Chemotherapy
  163. The ability of mannitol to decrease cisplatin-induced nephrotoxicity in children: real or not?
  164. Co-inheritance of G6PD and PK deficiencies in a neonate carrying aNovel UGT1A1genotype associated to Crigler-Najjar type II syndrome
  165. Neuropsychological Deterioration Predicts Tumor Progression in a Young Boy With Bithalamic Glioma
  166. Molecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and Treatment
  167. Temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: a broken promise?
  168. Paroxysmal Nocturnal Hemoglobinuria Clones in Children with Acquired Aplastic Anemia: A Multicentre Study
  169. Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial
  170. Critical Pulmonary Infection Due to Nontuberculous Mycobacterium in Pediatric Leukemia
  171. Platinum compounds in children with cancer
  172. Platinum compounds and sodium metabolism in children with diencephalic glioma
  173. Incidence, clinical features and management of hypersensitivity reactions to chemotherapeutic drugs in children with cancer
  174. Phase I study of temozolomide combined with oral etoposide in children with malignant glial tumors
  175. Safe lumbar puncture under analgo-sedation in children with acute lymphoblastic leukemia
  176. Salivary alpha-amylase: a new non-invasive biomarker for assessment of pain perception in epileptic children
  177. Efficacy and safety of transdermal buprenorphine in the management of children with cancer-related pain
  178. Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemia
  179. Azole interactions with multidrug therapy in pediatric oncology
  180. Cardiac Metastases of Ewing Sarcoma Detected by 18F-FDG PET/CT
  181. Vaccination in children with cancer: a debate
  182. Chronic Idiopathic Thrombocytopenic Purpura in children: predictive factors and outcome
  183. Treatment of pharyngeal non-Hodgkin lymphoma in a patient with Wiskott-Aldrich syndrome
  184. Expression of liquoral neuroprotection markers in children with acute lymphoblastic leukemia
  185. How to manage vaccinations in children with cancer
  186. The role of diet on the clinical pharmacology of oral antineoplastic agents
  187. Management of children with Thrombocytopenia-absent radius syndrome: An institutional experience
  188. Gastric Adenocarcinoma Presenting as Thrombotic Microangiopathy in a 14-year-old Girl
  189. Massive venous thrombosis of inferior vena cava as primary manifestation of renal Ewing’s sarcoma
  190. Comparison of propofol versus propofol-ketamine combination in pediatric oncologic procedures performed by non-anesthesiologists
  191. Tension Chylothorax Complicating Acute Malignant Airway Obstruction
  192. Topical Nerve Growth Factor as a Visual Rescue Strategy in Pediatric Optic Gliomas
  193. Pretreatment neuropsychological deficits in children with brain tumors
  194. Treatment of advanced neuroblastoma in children over 1 year of age: The critical role of 131 I-metaiodobenzylguanidine combined with chemotherapy in a rapid induction regimen
  195. Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma
  196. Intranasal lidocaine and midazolam for procedural sedation in children
  197. Hepatic Veno-Occlusive Disease
  198. Feasibility study of 21-day-on/7-day-off temozolomide in children with brain tumors
  199. Propofol/alfentanil and propofol/ketamine procedural sedation in children with acute lymphoblastic leukaemia: safety, efficacy and their correlation with pain neuromediator expression
  200. Intravenous Immunoglobulin therapy for anti-E hemolytic disease in the newborn
  201. Groshong catheter-related complications in children with cancer
  202. Familial hypobetalipoproteinemia: early neurological, hematological, and ocular manifestations in two affected twins responding to vitamin supplementation
  203. Interactions between antiepileptic and chemotherapeutic drugs in children with brain tumors: Is it time to change treatment?
  204. Aplastic anaemia in childhood. Description of two cases and review of the literature
  205. Severe hyperleukocytosis and multifocal intracranial haemorrhage: not always a fatal outcome
  206. The Neurofibromatosis type 1:A dominantly inherited tumors-predisposing disorder
  207. Transdermal buprenorphine in children with cancer-related pain
  208. Noninvasive ventilation in large postoperative flail chest
  209. Nocturnal Enuresis in Children: A Review of the Literature
  210. Safety and efficacy of two protocols for sedation in pediatric oncology procedures
  211. Longitudinal assessment of childhood optic gliomas: relationship between flicker visual evoked potentials and magnetic resonance imaging findings
  212. Stevens-Johnson syndrome in children receiving phenobarbital therapy and cranial radiotherapy
  213. Paediatric Kikuchi–Fujimoto disease: A benign cause of fever and lymphadenopathy
  214. Assessment of chemotherapy-induced anemia in children with cancer
  215. ANTHRACYCLINE CARDIOTOXICITY IN CHILDHOOD
  216. Patient-controlled analgesia with fentanil and midazolam in children with postoperative neurosurgical pain
  217. Stevens-Johnson syndrome in children receiving phenobarbital therapy and cranial radiotherapy
  218. Homotoxicological remedies versus desmopressin versus placebo in the treatment of enuresis: a randomised, double-blind, controlled trial
  219. Reply to Dr Christopher S Greeley
  220. MRI findings in Shwachman diamond syndrome
  221. Safety and efficacy of fentanyl administered by patient controlled analgesia in children with cancer pain
  222. A newborn with multiple fractures as first presentation of infantile myofibromatosis
  223. Acute aseptic meningitis inducing migraine-like attacks in a 7-year-old child
  224. Rosai-Dorfman Disease
  225. Phase II study of a protracted irinotecan schedule in children with refractory or recurrent soft tissue sarcoma
  226. CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDREN: Case Reports of Spontaneous Recovery Without Splenectomy
  227. Phase II trial of temozolomide in children with recurrent high-grade glioma
  228. Life-threatening presentation of mediastinal neoplasms: report on 7 consecutive pediatric patients
  229. SECOND CASE OF HEPATOBLASTOMA IN A YOUNG PATIENT WITH SIMPSON-GOLABI-BEHMEL SYNDROME
  230. Critical presentation of pleuropulmonary blastoma
  231. Massive Congenital Intracranial Teratoma Perioperative Coagulation Impairment
  232. Candida parapsilosisBloodstream Infection in Pediatric Oncology Patients: Results of an Epidemiologic Investigation
  233. Neurotrophic factor expression in childhood low-grade astrocytomas and ependymomas
  234. A CASE OF ACUTE LYMPHOBLASTIC LEUKEMIA PRESENTING AS SEVER HYPERCALCEMIA
  235. A fast visual evoked potential method for functional assessment and follow-up of childhood optic gliomas
  236. COMMENTS ON: Megadose Methylprednisolone for the Treatment of Patients with Evans Syndrome
  237. MALIGNANT RETROPERITONEAL PARAGANGLIOMACase Report and Review of the Literature
  238. Pulmonary Hemorrhage Complicating a Typical Hemolytic-Uremic Syndrome
  239. Pharmacokinetics of temozolomide given three times a day in pediatric and adult patients
  240. Management of critically ill children with mediastinal neoplasms: A 6-year survey from a single institution
  241. Microangiopathic Hemolytic Anemia Complicating a Postneonatal Pertussis Pneumonia
  242. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia
  243. Cellular and molecular aspects of drugs of the future: oxaliplatin
  244. High Response Rate to Cisplatin/Etoposide Regimen in Childhood Low-Grade Glioma
  245. Interventions for anemia in pediatric cancer patients
  246. Plasma Antidiuretic Hormone Levels in Children with Spina bifida
  247. CARCINOID TUMORS OF THE APPENDIX IN CHILDREN: Two Case Reports and Review of the Literature
  248. Primary Nocturnal Enuresis and Left-handedness
  249. Diamond–Blackfan Anemia and Midline Defects
  250. Two Different Desmopressin (DDAVP) Regimens in Enuretic Monozygotic Twins with Allergic Diathesis
  251. Early Reactive Neutrophil Changes in an Infant With Kawasaki Syndrome
  252. Hypersensitivity Reactions to Drugs